comparemela.com

Latest Breaking News On - Saniona - Page 5 : comparemela.com

Saniona AB: Saniona Initiates Multiple Ascending Dose Stage of SAN711 Phase 1 Clinical Trial

PRESS RELEASE February 10, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today provided an update on progress in its Phase 1 clinical trial

United statesTrista morrisonRudolf baumgartnerHead of clinical development at sanionaChief medical officerClinical developmentChief communications officerNasdaq stockholm small

Saniona AB: Saniona to participate in multiple upcoming virtual investor conferences

PRESS RELEASE January 5, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming virtual

United statesTrista morrisonEventupdate janHc andersen capital company introductionSci partnersAnnual corporate accessChief communicationsRami levinChief communications officerNasdaq stockholm smallUpdate jan feb

Saniona AB: Saniona Initiates Phase 2b Clinical Trial of Tesomet for Prader-Willi Syndrome

PRESS RELEASE December 28, 2021 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced the initiation of a Phase 2b clinical trial of Tesomet

United statesNew zealandUnited kingdomTrista morrisonPaige rivardRudolf baumgartnerMerling butlerUniversity of kansas medical centerInternational prader willi syndrome organisationTrial initiation pressFoundation for prader willi researchPrader willi syndrome association united statesHead of clinical development at sanionaBehavioral sciencesDivision of researchChief medical officer

Saniona AB: Saniona Chairman J Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market

PRESS RELEASE December 2, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the Chairman and the CEO, as well as additional

United statesTrista morrisonChief communications officerNasdaq stockholm smallPurchase dec

Saniona Chairman J Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market

PRESS RELEASE December 2, 2021 Saniona , a clinical stage biopharmaceutical company focused on rare diseases, today announced that the Chairman and the CEO, as well as additional members of the. | December 2, 2021

United statesTrista morrisonGlobenewswire incRami levinChief communications officerNasdaq stockholm small capSaniona ab publ stock exchangePress releaseF sanion se0005794617

vimarsana © 2020. All Rights Reserved.